Clinical Trial Update: Ustekinumab in BEhçet's Syndrome STudy

View source ↗

Summary

Clinical trial evaluating ustekinumab for Behçet's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil | Conditions: Behçet's Syndrome (BS) | Status: RECRUITING